L. Schilling et al., CHARACTERIZATION OF THE RELAXANT ACTION OF UROCORTIN, A NEW PEPTIDE RELATED TO CORTICOTROPIN-RELEASING FACTOR IN THE RAT ISOLATED BASILAR ARTERY, British Journal of Pharmacology, 125(6), 1998, pp. 1164-1171
1 In addition to its well established neuroendocrine and neurotransmit
ter effects, corticotropin releasing factor (CRF) exerts a potent vaso
relaxant action. Recently, a CRF-related peptide, urocortin, has been
identified in the mammalian brain. In the present study, the cerebral
vasomotor action of this peptide and the mechanism underlying its rela
xant effect are characterized. 2 Ring segments obtained from the rat b
asilar artery were used for measurement of isometric force. The relaxa
nt action of urocortin, CRF and sauvagine was studied in segments with
a functionally intact endothelium. 3 In segments precontracted with p
rostaglandin F-2 alpha, urocortin, CRF and sauvagine induced concentra
tion-related relaxation. The order of potency was as follows (pD(2)+/-
s.e.m. given in brackets): urocortin (9.32+/-0.07) > sauvagine (9.08+/
-0.08) > CRF (7.50+/-0.07). Complete relaxation was achieved with each
agonist. Relaxation was not affected by removal of the endothelium bu
t was markedly attenuated in segments precontracted with 50 mM K+ Kreb
s solution. The relaxant effect of urocortin was inhibited by astressi
n in an apparently competitive manner. A pA(2) value of 7.52 was estim
ated for astressin. Inhibition of urocortin-induced relaxation was als
o observed in the presence of the adenylate cyclase inhibitor SQ22536
(pD(2) in the presence of 300 mu M SQ22536, 9.36+/-0.05) and the Kf ch
annel blockers tetraethylammonium (10 mM; pD2, 8.65+/-0.07), iberiotox
in (100 nM; pD(2), 8.88+/-0.08) and apamin (10 nM; pD(2), 8.94 +/- 0.0
7). However, the inhibitory actions of SQ22536 and apamin or iberiotox
in were not additive. 4 The results suggest that urocortin induces rel
axation of cerebral arteries by activating CRF-R-2 receptors present i
n the vascular wall. Relaxation appears to be mediated by adenylate cy
clase stimulation and activation of Ca2+-dependent K+ channels.